COVID-19疫苗接种对老年人门诊抗生素处方的影响:自我对照风险区间研究
该研究纳入2020年12月至2022年12月接种第一、二和/或第三剂COVID-19疫苗的≥65岁成人,采用自我对照风险区间设计,比较接种后与接种前区间抗生素处方 odds。结果显示接种后任何抗生素和呼吸道抗生素处方 odds 降低,泌尿道抗生素处方无关联,SARS-CoV-2检测阳性率高时期抗生素处方减少更明显。
要点
- 接种后任何抗生素处方 aOR 为0.973(95%CI 0.968-0.978),低于接种前。
- 接种后呼吸道抗生素处方 aOR 为0.961(95%CI 0.953-0.968),低于接种前。
- 接种后泌尿道抗生素处方 aOR 为0.996(95%CI 0.987-1.006),无关联。
核心结论
- COVID-19疫苗接种与老年人门诊抗生素处方减少相关,尤其在SARS-CoV-2高流行时期。
研究设计与样本
- 自我对照风险区间研究,纳入2020年12月至2022年12月接种第一、二和/或第三剂COVID-19疫苗的≥65岁成人,共469 923剂疫苗符合纳入标准。
主要发现
- 接种后区间任何抗生素处方 aOR 为0.973(95%CI 0.968-0.978),低于接种前区间。
- 接种后区间呼吸道抗生素处方 aOR 为0.961(95%CI 0.953-0.968),低于接种前区间。
- 接种后区间泌尿道抗生素处方 aOR 为0.996(95%CI 0.987-1.006),与接种前区间无关联。
- SARS-CoV-2检测阳性率>10%时期任何抗生素处方 aOR 为0.875(95%CI 0.845-0.905),阳性率<5%时期 aOR 为0.996(95%CI 0.989-1.003)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronavirus disease 2019 (COVID-19) vaccination has been associated with reduced outpatient antibiotic prescribing among older adults with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We assessed the impact of COVID-19 vaccination on outpatient antibiotic prescribing in the broader population of older adults, regardless of SARS-CoV-2 infection status. METHODS: We included adults aged ≥65 years who received their first, second, and/or third COVID-19 vaccine dose from December 2020 to December 2022. We used a self-controlled risk-interval design and included cases who received an antibiotic prescription 2-6 weeks before vaccination (pre-vaccination or control interval) or after vaccination (post-vaccination or risk interval). We used conditional logistic regression to estimate the odds of being prescribed (1) any antibiotic, (2) a typical "respiratory" infection antibiotic, or (3) a typical "urinary tract" infection antibiotic (negative control) in the post-vaccination interval versus the pre-vaccination interval. We accounted for temporal changes in antibiotic prescribing using background monthly antibiotic prescribing counts. RESULTS: 469 923 vaccine doses met inclusion criteria. The odds of receiving any antibiotic or a respiratory antibiotic prescription were lower in the post-vaccination versus pre-vaccination interval (aOR, .973; 95% CI, .968-.978; aOR, .961; 95% CI, .953-.968, respectively). There was no association between vaccination and urinary antibiotic prescriptions (aOR, .996; 95% CI, .987-1.006). Periods with high (>10%) versus low (<5%) SARS-CoV-2 test positivity demonstrated greater reductions in antibiotic prescribing (aOR, .875; 95% CI, .845-.905; aOR, .996; 95% CI, .989-1.003, respectively). CONCLUSIONS: COVID-19 vaccination was associated with reduced outpatient antibiotic prescribing in older adults, especially during periods of high SARS-CoV-2 circulation.
引用
- Jorgensen SCJ, Brown K, Clarke AE, et al. The Effect of COVID-19 Vaccination on Outpatient Antibiotic Prescribing in Older Adults: A Self-Controlled Risk-Interval Study. Clin Infect Dis. 2024. PMID: 38700036. doi:10.1093/cid/ciae182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。